Tag: Nasdaq:MNKD
MannKind and United Therapeutics Achieve a Major Milestone in the Development...
Tyvaso DPI includes the second compound formulated with MannKind’s Technosphere® technology to be reviewed by the FDAFDA review expected to be complete in...
MannKind and Thirona Bio Join Forces to Evaluate Potential Inhaled Therapy...
MannKind will conduct formulation and preclinical studies of a new chemical entity owned by Thirona In addition, MannKind purchased a convertible note issued...